Characterization of purified New Delhi metallo-β-lactamase-1

Pei W Thomas1, Min Zheng, Shanshan Wu

  • 1Division of Medicinal Chemistry, College of Pharmacy, The University of Texas, Austin, Texas 78712, USA.

Biochemistry
|October 28, 2011
PubMed

Insights

New Delhi metallo-β-lactamase-1 (NDM-1) is a global antibiotic resistance threat. This study characterizes NDM-1, revealing its zinc-binding sites and catalytic activity, crucial for developing new therapeutics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Microbiology

Background:

  • New Delhi metallo-β-lactamase-1 (NDM-1) confers resistance to most beta-lactam antibiotics.
  • NDM-1 is a significant global health threat due to its plasmid-mediated transmission and presence in various infections.

Purpose of the Study:

  • To elucidate the molecular basis of NDM-1's antibiotic resistance.
  • To characterize the purified NDM-1 enzyme and its metal ion interactions.

Main Methods:

  • Recombinant expression and purification of NDM-1 in Escherichia coli.
  • Enzyme kinetics, UV-vis spectroscopy, and molecular dynamics simulations.
  • Characterization of metal ion binding affinities and enzyme activity with various beta-lactam substrates.

Main Results:

  • NDM-1 is processed to a truncated form, monomeric, and binds zinc ions with different affinities.
  • The active site dinuclear metal cluster is structurally similar to other class B1 metallo-β-lactamases.
  • Enzyme activity is modulated by zinc ion concentration, with maximal activity observed at ~10 μM ZnSO(4).

Conclusions:

  • Understanding NDM-1's molecular mechanisms is key to combating antibiotic resistance.
  • This research provides a foundation for developing targeted therapeutics against NDM-1.